Insider · CIK 0001624783
Richard Anthony Cunningham
Files at ANEB (Anebulo Pharmaceuticals, Inc.). First filing -, latest -.
In brief
Richard Anthony Cunningham files SEC Form 4 as CEO and director at ANEB (Anebulo Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Richard Anthony Cunningham has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 4, 2025 | ANEB Anebulo Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +316,352 | $0.00 | $0 | 316,352 | Apr 7, 2025 |
| Dec 9, 2024 | ANEB Anebulo Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +254,433 | $0.00 | $0 | 254,433 | Dec 10, 2024 |
| Oct 6, 2023 | ANEB Anebulo Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +600,000 | $0.00 | $0 | 600,000 | Oct 11, 2023 |
Questions about Richard Anthony Cunningham
Answered from the filings on this page, as of the latest one.
Is Richard Anthony Cunningham buying or selling?
Richard Anthony Cunningham has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Richard Anthony Cunningham's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Richard Anthony Cunningham has 0.
Where does Richard Anthony Cunningham file Form 4?
Richard Anthony Cunningham has filed Form 4 at ANEB (Anebulo Pharmaceuticals, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.